MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01496cam a22003017a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
15393936 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20150625124048.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
080802s2008 dcu b 000 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2008298577 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780309118668 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
SEKU |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA 644.I6 |
| Item number |
I57 |
| 110 2# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
Institute of Medicine (U.S.). |
| Subordinate unit |
Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Antivirals for pandemic influenza : |
| Remainder of title |
guidance on developing a distribution and dispensing program |
| Statement of responsibility, etc. |
Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Washington, DC : |
| Name of publisher, distributor, etc. |
National Academies Press, |
| Date of publication, distribution, etc. |
c2008 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
122 p. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references (p. 87-92). |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Introduction -- Antiviral effectiveness, safety, and supply -- Ethics, decision making, and communication ethics -- Who should get antivirals and where? |
| 536 ## - FUNDING INFORMATION NOTE |
|---|
| Text of note |
Supported by the National Academy of Sciences and the Dept. of Health and Human Services |
| Contract number |
HHSP 23320042509X1 |
| Task number |
HHSP233200700006T |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Influenza |
| Geographic subdivision |
United States |
| General subdivision |
Epidemiology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Influenza |
| General subdivision |
Vaccination |
| Geographic subdivision |
United States. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Influenza |
| General subdivision |
Prevention. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antiviral agents. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antiviral agents |
| General subdivision |
Effectiveness. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Epidemics |
| General subdivision |
Prevention. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Library of Congress Classification |
| Koha item type |
General circulation |